Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion type Assertion NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_head.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion description "[Two recent clinical trials have shown that the placenta growth factor (PlGF) is up-regulated after bevacizumab treatment in colorectal cancer and after SU11248 treatment in metastatic renal cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_provenance.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion evidence source_evidence_literature NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_provenance.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion SIO_000772 17704140 NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_provenance.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion wasDerivedFrom befree-2016 NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_provenance.
- NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_assertion wasGeneratedBy ECO_0000203 NP625638.RAV_-caE-ipZ_YLywEXmBOQlBP5si-AG3gVcf4iR4Pqt8130_provenance.